Právní předpis byl sestaven k datu 04.01.2012.
Zobrazené znění právního předpisu je účinné od 04.01.2012 do 04.01.2012.
Nařízení vlády, kterým se pro účely trestního zákoníku stanoví, co se považuje za jedy a jaké je množství větší než malé u omamných látek, psychotropních látek, přípravků je obsahujících a jedů
467/2009 Sb.
Příloha č. 1 - Chemické látky, které se pro účely trestního zákoníku považují za jedy
nález Ústavního soudu - č. 259/2013 Sb.
467
XXXXXXXX XXXXX
ze dne 14. xxxxxxxx 2009,
xxxxxx xx xxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxx, xx xx xxxxxxxx xx xxxx x jaké xx xxxxxxxx xxxxx než xxxx u omamných xxxxx, psychotropních xxxxx, xxxxxxxxx xx obsahujících x jedů
Xxxxx nařizuje podle §289 xxxx. 2 xxxxxx x. 40/2009 Xx., xxxxxxx xxxxxxx:
§1
x) xxxxxxxx xxxxx xxxxxxx x příloze č. 1 x tomuto xxxxxxxx (xxxx xxx "látky"),
x) xxxxxxxx xxxxx, xxxxx obsahují xxxxxxx 7 % xxxxx.
(2) X xxxxx xxxxxxxxx x příloze č. 1 x xxxxxx xxxxxxxx xx xx xxxxxxxx xxxxx než xxxx xxxxxxx xxxxxx množství xxxx, xxxxx xx xxxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxxx xxxx xx xxxxxxxxxxxx xxxx xxxxxxxxxx xxxxxx způsobit xxxxxxxxx xxxxxx.
Xxxxxxx znění - xxxxxxxx xx 1.1.2010 xx 22.8.2013 (xx xxxxxx č. 259/2013 Xx.)
§2
Xxxxxxx určující xxxxxxxx xxxxx xxx malé x xxxxxxxx látek, xxxxxxxxxxxxxx látek a xxxxxxxxx xx xxxxxxxxxxxx xxxx uvedeny v xxxxxxx x. 2 x xxxxxx xxxxxxxx.
§3
Xxxx xxxxxxxx nabývá účinnosti xxxx 1. xxxxx 2010.
Xxxxxxxx xxxxx:
Xxx. Fischer, XXx. x. x.
Ministryně xxxxxxxxxxxxx:
XXXx. Kovářová x. x.
Xxxxxxx č. 1 x nařízení xxxxx x. 467/2009 Xx.
Xxxxxxxx xxxxx, které se xxx xxxxx xxxxxxxxx xxxxxxxx považují xx xxxx
|
Xxxxx xxxxxx xxxxxxx xxxxxxxx xxxxx
|
Xxxxx XXX
|
Xxxxx XX
|
Xxxxxxxx xxxxx
|
|
Xxxxxxxx
|
302-27-2
|
206-121-7
|
614-008-00-2
|
|
Xxxxxxxx, soli
|
-
|
-
|
614-009-00-8
|
|
Akrylaldehyd; xxxx-2-xxxx; akrolein
|
107-02-8
|
203-453-4
|
605-008-00-3
|
|
Aldikarb (XXX); 2-xxxxxx-2-(xxxxxxxxxxxxxx)xxxxxxxx-X-(X-xxxxxxxxxxxxxxx)xxxx
|
116-06-3
|
204-123-2
|
006-017-00-X
|
|
Xxxxxxxxxxxxx
|
-
|
-
|
082-002-00-1
|
|
XXXX (XXX); (1-naftyl)thiomočovina; 1-(1-xxxxxx) xxxxxxxxxxxx
|
86-88-4
|
201-706-3
|
006-008-00-0
|
|
Xxxxxxxxxxx; arsin; xxxxx
|
7784-42-1
|
232-066-3
|
033-006-00-7
|
|
Xxxxxxx; endo-(±)-8-methyl-8-azabicyklo[3.2.1]oktan-3-yl-fenyl(hydroxymethyl)acetát
|
51-55-8
|
200-104-8
|
614-010-00-3
|
|
Atropin, soli; xxxx-(±)-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-3-xx-xxxxx(xxxxxxxxxxxxX)xxxxxx, xxxx
|
-
|
-
|
614-011-00-9
|
|
Xxxx xxxxx
|
26628-22-8
|
247-852-1
|
011-004-00-7
|
|
Xxxxxxx-xxxxx (XXX); O,O-diethyl-S-[4(3H)- oxo-1,2,3-benzotriazin -3-xx)xxxxxx]-xxxxxxxxxxxxxxx
|
2642-71-9
|
220-147-6
|
015-056-00-1
|
|
Xxxxxxx-xxxxxx (XXX); O,O-dimethyl-S-[4(3H)-oxo-1,2,3-benzotriazin-3-yl)-methyl]-fosforodithioát
|
86-50-0
|
201-676-1
|
015-039-00-9
|
|
Aziridin; xxxxxxxxxxx
|
151-56-4
|
205-793-9
|
613-001-00-1
|
|
Xxxxxxxxxxx (ISO); xxxxxxxxxxxxx(1X-1,2,4-xxxxxxx-1-xx)xxxxxxx; 1-(xxxxxxxxxxxxxxxxxxxx)-1X-1,2,4-xxxxxxx
|
41083-11-8
|
255-209-1
|
050-019-00-3
|
|
[(Xxxxxxxxxxxx-2-xx)xxxxxxxx]xxxxxxxxxxxxxxxx; XXXXX
|
21564-17-0
|
244-445-0
|
613-119-00-3
|
|
Xxxxxxxxx
|
7440-41-7
|
231-150-7
|
004-001-00-7
|
|
Xxxxxxxxx, xxxxxxxxxx (x xxxxxxxx křemičitanů xxxxxxxxxx-xxxxxxxxx)
|
-
|
-
|
004-002-00-2
|
|
2,2'-Xxxxxxxx; 1,2,3,4-xxxxxxxxxxxx
|
1464-53-5
|
215-979-1
|
603-060-00-1
|
|
Xxx(2-xxxxxxxxxx)xxxxx
|
111-44-4
|
203-870-1
|
603-029-00-2
|
|
Xxx(xxxxxxxxxxx)xxxxx; dichlormethylether
|
542-88-1
|
208-832-8
|
603-046-00-5
|
|
2,5-Bis(isokyanatomethyl)bicyklo[2.2.1]heptan
|
-
|
411-280-2
|
615-029-00-X
|
|
Bis (2,4,6-xxxxxxxxxxxxx) amin, 2,2',4,4',6,6'-xxxxxxxxxxxxxxxxxxxx; xxxxx; xxxxxxxxxxxx
|
131-73-7
|
205-037-8
|
612-018-00-1
|
|
Xxxxxxxxxxx-x; 5-[3-xxxxx-5-(1-xxxxxxxxxxxxxxx)xxxxxxxxxxx]-2-(4-xxxxx-2(1X) xxxxxxxxxxxx-1-xx)-5,6-xxxxxxx-2X-xxxxx-2-xxxxxxxxxxx kyselina
|
2079-00-7
|
-
|
607-155-00-9
|
|
Brodifakum; 3-[3-(4'-xxxxxxxxxxx-4-xx)-1,2,3,4-xxxxxxxxxx-1-xxxxxx]-4-xxxxxxx-2X-xxxxxxx-2-xx
|
56073-10-0
|
259-980-5
|
607-172-00-1
|
|
Xxxx
|
7726-95-6
|
231-778-1
|
035-001-00-5
|
|
Xxxxxx xxxxxx
|
10294-33-4
|
233-657-9
|
005-003-00-0
|
|
Xxxxxxxxxx (XXX); 3,5-dibrom-4-hydroxybenzonitril
|
1689-84-5
|
216-882-7
|
608-006-00-0
|
|
Bromoxynil (XXX) x jeho xxxx
|
-
|
-
|
608-065-00-2
|
|
Xxxxxx; 2,3-dimethoxystrychnidin-10-on
|
357-57-3
|
206-614-7
|
614-006-00-1
|
|
Brucin-(R)-1-methylheptyl-hydrogen-ftalát
|
68239-26-9
|
269-439-5[
|
614-007-00-7
|
|
Brucin-nitrát
|
5786-97-0
|
227-317-9
|
614-007-00-7
|
|
Brucin, sloučenina x (X)-(1-xxxxxxxxxxxx)-1,2-xxxxxx-1,2-xxxxxxxxxxxxxx (1:1)
|
68310-42-9
|
269-710-8
|
614-007-00-7
|
|
Xxxxxx-xxxxxx
|
4845-99-2
|
225-432-9
|
614-007-00-7
|
|
Xxx-2-xxxx; xxxxxxxxxxxxx
|
4170-30-3
|
224-030-0
|
605-009-00-9
|
|
(X)-Xxx-2-xxxx; (E)-krotonaldehyd
|
123-73-9
|
204-647-1
|
605-009-00-9
|
|
terc-Butylarsin; terc-butylarsan
|
4262-43-5
|
423-320-6
|
033-007-00-2
|
|
λ-cyhalothrin (XXX); xxxxxx-xxxxxxxxxxx; xxxx (1:1) (X)-[(3-xxxxxxxxxxx)xxxxxxxxxx]- (Z)-cis-3-(2-chlor-3,3,3-trifluorprop-1-en-1-yl)-2,2-dimethylcyklopropan-1-karboxylát x (S)-[(3-fenoxyfenyl)kyanmethyl]-(Z)-cis-3-(2-chlor-3,3,3-trifluorprop-1-en-1-yl)-2,2- xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx
|
91465-08-6
|
415-130-7
|
607-252-00-6
|
|
Xxxxxxxxxxxx; 4-[2-(3,5-xxxxxxxx-2-xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]xxxxxxxxx-2,6-xxxx
|
66-81-9
|
200-636-0
|
613-140-00-8
|
|
Xxxxxxxx-0 (XXX); O,O-dimethyl-0-[2-(methylsulfanyl)ethyl]-fosforothioát
|
682-80-4
|
211-666-9
|
015-116-00-7
|
|
Demefion-S (XXX); O,O-dimethyl-S-[2-(methylsulfanyl)ethyl]-fosforothioát
|
2587-90-8
|
219-971-9
|
015-117-00-2
|
|
Demeton;
|
8065-48-3
|
-
|
015-118-00-8
|
|
Demeton-O (XXX); X,X-xxxxxxx-X-[2-(xxxxxxxxxxxxx)xxxxx]-xxxxxxxxxxxxx
|
298-03-3
|
206-053-8
|
015-028-00-9
|
|
Xxxxxxx-X (ISO); O,O-diethyl-S-[2-(ethylsulfanyl)ethyl]-fosforothioát
|
126-75-0
|
204-801-8
|
015-029-00-4
|
|
Dialifos (XXX); S-(2-chlor-1-ftalimidoethyl)-O,O-diethyl-fosforodithioát
|
10311-84-9
|
233-689-3
|
015-088-00-6
|
|
Diazinon
|
333-41-5
|
206-373-8
|
015-040-00-4
|
|
Dibutylcín dichlorid
|
683-18-1
|
211-670-0
|
050-022-00-X
|
|
Dieldrin (XXX); 1,2,3,4,10,10-xxxxxxxxx-6,7-xxxxx-1,4,4x,5,6,7,8,8x- -xxxxxxxxx-1,4,5,8-xxxxxxxxxxxxxxxxx
|
60-57-1
|
200-484-5
|
602-049-00-9
|
|
Xxxxxxxxxxxxxxx-xxxxxxxx; (xxxxxxxxxxxx)-xxxxxxxx
|
693-21-0
|
211-745-8
|
603-033-00-4
|
|
Xxxxxxxxxxxxxxx-xxxxxxxx; (xxxxxxxxxxxx)-xxxxxxxx xxxxxxxxxxxxxx
|
693-21-0
|
211-745-8
|
603-033-01-1
|
|
Xxxxxxxxxxxxxxxxxxx
|
627-44-1
|
211-000-7
|
080-007-00-3
|
|
Xxxxxxxxx (XXX); 2-(difenylacetyl)indan-1,3-dion
|
82-66-6
|
201-434-5
|
606-038-00-X
|
|
Difenakum; 3-[3-(bifenyl-4-yl)-1,2,3,4-tetrahydro-1-naflyl]-4-hydroxy-2H-chromen-2-on
|
56073-07-5
|
259-978-4
|
607-157-00-X
|
|
6,7-Dihydropyrido [ 1,2-α:2, 1-x]xxxxxxxxxxxxxxx xxxxxxxxxx
|
94021-76-8
|
301-467-6
|
613-089-00-1
|
|
1-(3,4-Xxxxxxxxxxxxxx)xxxxxxxxxxxxxxxx
|
5836-73-7
|
-
|
616-016-00-1
|
|
1,4-Xxxxxxxxxx-2-xx
|
764-41-0
|
212-121-8
|
602-073-00-X
|
|
Xxxxxxxxxx (XXX); 2,2-xxxxxxxxxxxx-xxxxxxxx-xxxxxx
|
62-73-7
|
200-547-7
|
015-019-00-X
|
|
Xxxxxxxxx xxxxxx
|
7789-09-5
|
232-143-1
|
024-003-00-1
|
|
Xxxxxxxxx draselný
|
7778-50-9
|
231-906-6
|
024-002-00-6
|
|
Dichroman xxxxx xxxxxxx
|
10588-01-9
|
234-190-3
|
024-004-00-7
|
|
Xxxxxxxxx xxxxx, xxxxxxxx
|
7789-12-0
|
234-190-3
|
024-004-01-4
|
|
1,3-Xxxxxxxxxxxx-2-xxxxxxxxxxxx
|
91-08-7
|
202-039-0
|
615-006-00-4
|
|
1,3-Xxxxxxxxxxxx-4-xxxxxxxxxxxx
|
584-84-9
|
209-544-5
|
615-006-00-4
|
|
1,4-Xxxxxxxxxxxx-2-xxxxxxxxxxxx
|
26471-62-5
|
247-722-4
|
615-006-00-4
|
|
Xxxxxxxxxx (XXX); (Z)-[1-(N,N-dimethylkarbamoyl)prop-1-en-2-yl]-dimethyl-fosfát
|
141-66-2
|
205-494-3
|
015-073-00-4
|
|
Dikvat xxxxxxxx
|
85-00-7
|
201-579-4
|
613-089-00-1
|
|
Xxxxxx xxxxxxxxx
|
4032-26-2
|
223-714-6
|
613-089-00-1
|
|
Xxxxxxx (ISO); X,X,X',X'-xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
|
115-26-4
|
204-076-8
|
015-061-00-9
|
|
(2,2-Xxxxxxxx-2,3-xxxxxxx-1-xxxxxxxxxx-7-xx)-{X-[(X-xxxxxxxxxxxxxx-X-xxxxxxxxxxx)- xxxxxxxx]-X-xxxxxxxxxxxxxx}; xxxxxxxxxxxx
|
65907-30-4
|
265-974-3
|
006-087-00-1
|
|
Xxxxxxxx[1,1'-(xxxxxxxxxxxxxxxxx)xx((1,2,3,3x,7x-η)-1X-xxxxx-1-xx)xxxxxxx
|
137390-08-0
|
422-060-0
|
014-030-00-7
|
|
Xxxxxxxxxxxxxxxxxxxx
|
593-74-8
|
209-805-3
|
080-007-00-3
|
|
Xxxxxxxx-[4-(xxxxxxxxxxxxxx)xxxxx]-xxxxxx
|
3254-63-5
|
-
|
015-119-00-3
|
|
7,7-Xxxxxxxxxxxxxxxxxxxxxxx; xxxxxxxxxxxxxxxxxx
|
40292-82-8
|
254-875-0
|
607-313-00-7
|
|
X,X-Xxxxxxxxxxxxxxxxxxxxxxx
|
13360-57-1
|
236-412-4
|
016-033-00-9
|
|
Xxxxxxxx-xxxxxx
|
77-78-1
|
201-058-1
|
016-023-00-4
|
|
2,4-Xxxxxxxxxxxxx
|
97-02-9
|
202-553-5
|
612-040-00-1
|
|
Xxxxxxxxxxxxx
|
25154-54-5
|
246-673-6
|
609-004-00-2
|
|
1,2-Xxxxxxxxxxxxx
|
528-29-0
|
208-431-8
|
609-004-00-2
|
|
1,3-Xxxxxxxxxxxxx
|
99-65-0
|
202-776-8
|
609-004-00-2
|
|
1,4-Xxxxxxxxxxxxx
|
100-25-4
|
202-833-7
|
609-004-00-2
|
|
4,6-Xxxxxxx-x-xxxxxxxx xxxxxx
|
2980-64-5
|
221-037-0
|
609-022-00-0
|
|
Xxxxxxxx (XXX); 2-xxxx-xxxxx-4,6-xxxxxxxxxxxx
|
1420-07-1
|
215-813-8
|
609-030-00-4
|
|
Xxxxxxxx (XXX), xxxx a xxxxxx; 2-xxxx-xxxxx-4,6-xxxxxxxxxxxx, xxxx x estery
|
-
|
-
|
609-031-00-X
|
|
Dioxathion (XXX); X,X'-(1,4-xxxxxx-2,3-xxxx) (O,O,O',O'-tetraethylbis(fosforodithioát)
|
78-34-2
|
201-107-7
|
015-063-00-X
|
|
Dipikrylamin, amonná xxx; xxxxxx xxx xxxxxxxxxxxxx; amonná xxx xxxxxxxxxxxxxxxxxxxxx; amonná xxx 2,2',4,4',6,6'-xxxxxxxxxxxxxxxxxxxxx
|
2844-92-0
|
220-639-0
|
612-019-00-7
|
|
Xxxxxxxxxx (XXX); O,O-diethyl-S-[2-(ethylsulfanyl) xxxxx]-xxxxxxxxxxxxxxx
|
298-04-4
|
206-054-3
|
015-060-00-3
|
|
XXXX; 4,6-xxxxxxx-x-xxxxxx; 2-xxxxxx-4,6-xxxxxxxxxxxx
|
534-52-1
|
208-601-1
|
609-020-00-X
|
|
Xxxxxx (XXX); 1,2,3,4,10,10-hexachlor-6,7-epoxy-1,4,4a,5,6,7,8,8a-oktahydro- 1,4,5,8-xxxxxxxxxxxxxxxxx
|
72-20-8
|
200-775-7
|
602-051-00-X
|
|
Xxxxxxxxxx (XXX); 1,2,3,4,7,7-xxxxxxxxxxxxxxxx [2.2.1]hept-2-en-5,6-dimethanol, xxxxxxxx xxxxxx; 1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-en-2,3-ylenedimethyl xxxxxx
|
115-29-7
|
204-079-4
|
602-052-00-5
|
|
Xxxxxxxxxxxxxx; vitamin X2
|
50-14-6
|
200-014-9
|
603-179-00-9
|
|
Xxxxxxxxxx xxxxxx; 3,8-xxxxxxx-1-xxxxx-6-xxxxxxxxxxxxxxxxxxxx-xxxxxx
|
1239-45-8
|
214-984-6
|
612-278-00-6
|
|
Xxxxxxxxxx (XXX); X-xxxxx-X,X-xxxxxxxx-xxxxxxxxxxxxxxx
|
13194-48-4
|
236-152-1
|
015-107-00-8
|
|
Xxxxx-xxxxxxxxxx
|
105-36-2
|
203-290-9
|
607-069-00-1
|
|
Xxxxx-xxxxxxxxxxxx
|
541-41-3
|
208-778-5
|
607-020-00-4
|
|
Xxxxxxx-xxxxxxxx; xxxxxxxxxxxxx-xxxxxxxx; nitroglykol
|
628-96-6
|
211-063-0
|
603-032-00-9
|
|
O-Ethyl-O-(4-nitrofenyl)-fenylfosfonothioát; XXX
|
2104-64-5
|
218-276-8
|
015-036-00-2
|
|
X-[2-(Xxxxxxxxxxxxx)xxxxx]-X,X-xxxxxxxx-xxxxxxxxxxxxxxx
|
2703-37-9
|
-
|
015-065-00-0
|
|
Xxxxxxxxx (ISO); xxxxx-3-xxxxxx-4-(xxxxxxxxxxxxxx)xxxxx-X-xxxxxxxxxxxxxxxxxxxxx
|
22224-92-6
|
244-848-1
|
015-123-00-5
|
|
Xxxxxxxxxxxxxx (XXX); 1,1,1,3,3,3 -xxxxxxx(2-xxxxx-2-xxxxxxxxxxxx)xxxxxxxxxxx
|
13356-08-6
|
236-407-7
|
050-017-00-2
|
|
[(3-Xxxxxxxxxxx)xxxxxxxxxx]-2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx; xxxxxxxxxxxxx
|
39515-41-8
|
254-485-0
|
607-239-00-5
|
|
[(3-Xxxxxx-4-xxxxxxxxxx)xxxxxxxxxx]-3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1- xxxxxxxxxx; xxxxxxxxx
|
68359-37-5
|
269-855-7
|
607-253-00-1
|
|
[(3-Xxxxxx-4-xxxxxxxxxx)xxxxxxxxxx]-3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1- xxxxxxxxxx; (x-xxxxxxxxx; xxxx xxxxxxxxx
|
68359-37-5
|
269-855-7
|
607-254-00-7
|
|
Xxxxxxxxxxxxx (XXX); O,O-diethyl-O-[4-(methylsulfinyl)fenyl]-fosforothioát
|
115-90-2
|
204-114-3
|
015-090-00-7
|
|
Fentinacetát (XXX); xxxxxxx(xxxxxxxx)xxxxxxx
|
900-95-8
|
212-984-0
|
050-003-00-6
|
|
Xxxxxxxxxxxxxx (XXX), xxxxxxxx(xxxxxxx) xxxxxxx
|
76-87-9
|
200-990-6
|
050-004-00-1
|
|
Xxxxxxxxx (ISO); 2-xxxxxxxxxx-(xxxxxxx-4-xx)xxxxxx
|
4301-50-2
|
-
|
607-078-00-0
|
|
Xxxxx
|
7782-41-4
|
231-954-8
|
009-001-00-0
|
|
Xxxxxxxxxxxxx; 2-xxxxxxxxxxxxx
|
640-19-7
|
211-363-1
|
616-002-00-5
|
|
Xxxxxxx xxxxxx
|
7637-07-2
|
231-569-5
|
005-001-00-X
|
|
Xxxxxxx xxxxxxxxx
|
7790-79-6
|
232-222-0
|
048-006-00-2
|
|
Xxxxxxxxxx xxxxx
|
62-74-8
|
200-548-2
|
607-169-00-5
|
|
Xxxxxxxxxxx kyselina
|
144-49-0
|
205-631-7
|
607-081-00-7
|
|
Fluoroctová xxxxxxxx, xxxx xxxxxxxxx xx xxxx; xxxxxxxxxxxxx xxxxxxxxx xx xxxx
|
-
|
-
|
607-082-00-2
|
|
Xxxxxxxxxxx
|
7664-39-3
|
231-634-8
|
009-002-00-6
|
|
Xxxxxxx (XXX); O-ethyl-S-fenyl-ethylfosfonodithioát
|
944-22-9
|
213-408-0
|
015-091-00-2
|
|
Forát (XXX); 0,0-xxxxxxx-X-[(xxxxxxxxxxxxx)xxxxxx]-xxxxxxxxxxxxxxx
|
298-02-2
|
206-052-2
|
015-033-00-6
|
|
Xxxxxxxxxx (XXXX); 3-[(xxxxxxxxxxxxxxxxxxxxxxx)xxxxx]xxxxx-xxxxxxxxxxxxxx
|
22259-30-9
|
244-879-0
|
006-031-00-6
|
|
Xxxxxxxxxx-xxxxxxxxxxxx; 3-[(xxxxxxxxxxxxxxxxxxxxxx)xxxxx]xxxxx-xxxxxxxxxxxxxx xxxxxxxxxxxx
|
23422-53-9
|
245-656-0
|
006-052-00-0
|
|
Xxxxxxxxx (XXX); X,X-xxx(4-xxxxxxxxx)-X-xxxxxxxxxxxxxxxxxxxxxxxxxxxx
|
4104-14-7
|
223-874-7
|
015-092-00-8
|
|
Xxxxxxxxxx; [2-xxxxx-2-(xxxxxxxxxxxxxxxxx)-1-xxxxxxxxxxx]-xxxxxxxx-xxxxxx
|
13171-21-6
|
236-116-5
|
015-022-00-6
|
|
Xxxxxx xxxxxxx
|
20859-73-8
|
244-088-0
|
015-004-00-8
|
|
Xxxxxx xxxxxxxxx
|
12057-74-8
|
235-023-7
|
015-005-00-3
|
|
Xxxxxx vápenatý
|
1305-99-3
|
215-142-0
|
015-003-00-2
|
|
Fosfid zinečnatý
|
1314-84-7
|
215-244-5
|
015-006-00-9
|
|
Fosfin;fosfan
|
7803-51-2
|
232-260-8
|
015-181-00-1
|
|
Fosfolan (XXX); xxxxxxx-X-(1,3-xxxxxxxxx-2-xxxxxx)xxxxxxxxxxxx
|
947-02-4
|
213-423-2
|
015-111-00-X
|
|
Xxxxxx xxxx
|
12185-10-3
|
231-768-7
|
015-001-00-1
|
|
Xxxxxxxxxx (XXX); xxxxxxx-X-(1,3-xxxxxxxxx-2-xxxxxx)xxxxxxxxxxxx
|
21548-32-3
|
244-437-7
|
015-124-00-0
|
|
Xxxxxxxxxxx; 1,3x,8-xxxxxxxxx-2,3,3x,8x-xxxxxxxxxx-1X,8X-xxxxxxx[2,3-x]xxxxx-5-xx -X-xxxxxxxxxxxxxx; xxxxxx
|
57-47-6
|
200-332-8
|
614-020-00-8
|
|
Xxxxxxxxxxx, soli; 1,3x,8-xxxxxxxxx-2,3,3x,8x-xxxxxxxxxx-1X,8X-xxxxxxx[2,3-x]xxxxx -5-xx-X-xxxxxxxxxxxxxx, xxxx; xxxxxx, xxxx
|
-
|
-
|
614-021-00-3
|
|
Xxxxxxxx (XXX); 1,1'-[xxxxxxx(xxxxx-8,1-xxxx)]xxxxxxxx
|
13516-27-3
|
236-855-3
|
612-087-00-3
|
|
Xxxxxxxx (ISO); 1,1'-[xxxxxxx(xxxxx-8,1-xxxx)]xxxxxxxx
|
108173-90-6
|
-
|
612-087-00-8
|
|
Xxxxxxxxxxxxxxxxxxx-1,3-xxxx
|
77-47-4
|
201-029-3
|
602-078-00-7
|
|
2-Xxxxxxx-2-xxxxxxxxxxxxxxxxxx; xxxxxxxxxxxxxxxx; 2-xxxxxxxxxx-2-xx
|
75-86-5
|
200-909-4
|
608-004-00-X
|
|
Xxxxxxxxxx; ((3S)-endo-8-methyl-8-azabicyklo[3.2.1]oktan-3-y])-2-fenyl-2-(hydroxymethyl)acetát
|
101-31-5
|
202-933-0
|
614-012-00-4
|
|
Hyoscyamin, xxxx; ((3S)-endo-8-methyl-8-azabicyklo[3.2.1]oktan-3-yl)-2-fenyl-2 (xxxxxxxxxxxxx)xxxxxx, xxxx
|
-
|
-
|
614-013-00-X
|
|
Xxxxxxxxxxxx; xxxxxxxxxxxxxxxx
|
107-20-0
|
203-472-8
|
605-025-00-6
|
|
2-Xxxxxxxxxx-1-xx; ethylenchlorhydrin
|
107-07-3
|
203-459-7
|
603-028-00-7
|
|
(4-Chlorfenyl)isokyanát
|
104-12-1
|
203-176-9
|
615-044-00-1
|
|
Chlorfenvinfos (XXX); [2-xxxxx-1-(2,4-xxxxxxxxxxxx)xxxxx]-xxxxxxx-xxxxxx
|
470-90-6
|
207-432-0
|
015-071-00-3
|
|
Xxxxxxx boritý
|
10294-34-5
|
233-658-4
|
005-002-00-5
|
|
Chlorid xxxxxxxxxx
|
10026-13-8
|
233-060-3
|
015-008-00-X
|
|
Xxxxxxx fosforitý
|
7719-12-2
|
231-749-3
|
015-007-00-4
|
|
Chlorid kademnatý
|
10108-64-2
|
233-296-7
|
048-008-00-3
|
|
Chlorid xxxxxxxxx; fosgen
|
75-44-5
|
200-870-3
|
006-002-00-8
|
|
Chlorid xxxxxxxx
|
7487-94-7
|
231-299-8
|
080-010-00-X
|
|
X-(5-Xxxxx-1-xxxxxxxxx-1X-1,2,4-xxxxxxx-3-xx)-X,X-xxxxxxx-xxxxxxxxxxxxx; xxxxxxxx
|
42509-80-8
|
255-863-8
|
015-153-00-9
|
|
5-Xxxxx-6-X-{[(xxxxxxxxxxxxxxx)xxx]xxxxx}xxxxxxx[2.2.1]xxxxxx-2-xxxxxxxxxxx; xxxxxxx
|
15271-41-7
|
-
|
006-065-00-1
|
|
Xxxxxxxxxx (ISO); X-xxxxxxxxxxx-X,X-xxxxxxx-xxxxxxxxxxxxxxx
|
24934-91-6
|
246-538-1
|
015-114-00-6
|
|
Xxxxxxxxxxxxxxxxx
|
-
|
-
|
610-006-00-0
|
|
Xxxxxxxxxxxxx (XXX); 2-[2-(4-xxxxxxxxxx)-2-xxxxxxxxxxx]xxxxx-1,3-xxxx
|
3691-35-8
|
223-003-0
|
606-014-00-9
|
|
Xxxxxxxxxxxxx (XXX); xxxxxxxxxxxxxxxxxxxxxxxx
|
1897-45-6
|
217-588-1
|
608-014-00-4
|
|
Xxxxxxxxxxxx (XXX); X-[2,5-xxxxxxx-4-(xxxxxxxxxxxxxx)xxxxx]-X,X-xxxxxxx-xxxxxxxxxxxxx
|
21923-23-9
|
244-663-6
|
015-115-00-1
|
|
2-Xxxxx-1,3,5-xxxxxxxxxxxxxx
|
88-88-0
|
201-864-3
|
610-004-00-X
|
|
Xxxxxxxxxxxxxxx; xxxxxxx X3
|
67-97-0
|
200-673-2
|
603-180-00-4
|
|
Xxxxxxx xxxxx
|
7775-11-3
|
231-889-5
|
024-018-00-3
|
|
3,3'-xxxxxxx(xxxxxx-1-xxxx); xxxxxxxxxxxxxxxxx
|
56-18-8
|
200-261-2
|
612-063-00-7
|
|
XXXX (JMAFF); X-[(xxxxxxxxxxxxx)xxxxxx]-X,X-xxxxxxxxxxx-xxxxxxxxxxxxxxx
|
5827-05-4
|
-
|
015-128-00-2
|
|
Xxxxxxxxx (ISO); 1,3,4,5,6,7,8,8-oktachlor-3a,4,7,7a-tetrahydro-4,7- xxxxxx-1X,3X-xxxxxxxxxxxxx
|
297-78-9
|
206-045-4
|
602-053-00-0
|
|
Xxxxxxx; (1x,4x,4x(3,5(3,8(3,8x(3)-1,2,3,4,10,10-xxxxxxxxx-1,4,4x,5,8,8x- xxxxxxxxx-1,4,5,8-xxxxxxxxxxxxxxxxx
|
465-73-6
|
207-366-2
|
602-050-00-4
|
|
Xxxxxx; (1-xxxxxxxxx-3-xxxxxxxxxxxxx-5-xx)-xxxxxxxxxxxxxxxx
|
119-38-0
|
204-318-2
|
006-009-00-6
|
|
[2-(4-(xxxxxxxxxxxxxxxx) xxxxxx-2-xx]xxxxxxxxx
|
2094-99-7
|
402-440-2
|
006-074-00-0
|
|
Xxxxxxx (xxxxxxxxxxxxx)
|
7440-43-9
|
231-152-8
|
048-002-00-0
|
|
Xxxxxxx (xxxxxxxxxxx)
|
7440-43-9
|
231-152-8
|
048-011-00-X
|
|
Xxxxxxxxxx (XXX); 2,2-xxxxxxxx-2,3-xxxxxxx-1-xxxxxxxxxx-7-xx-xxxxxxxxxxxxxx
|
1563-66-2
|
216-353-0
|
006-026-00-9
|
|
Xxxxxxxxxxx (XXX); 2,2-xxxxxxxx-2,3-xxxxxxx-1-xxxxxxxxxx-7-xx-X-(xxxxxxxxxxxx)xxxxxxxx-X-xxxxxxxxxxxxxx
|
55285-14-8
|
259-565-9
|
006-084-00-5
|
|
Xxxxxx-xxxxxxx-xxxx-xxxx
|
-
|
442-750-5
|
028-058-00-2
|
|
Xxxxxxxxx; (6X)-X-(1,2,3,10-xxxxxxxxxxxx-9-xxx-5,6,7,9-xxxxxxxxxxxxxxx[x]xxxxxxxx- 7-xx)xxxxxxxx
|
64-86-8
|
200-598-5
|
614-005-00-6
|
|
Xxxxxxxx (XXX); X-(2-xxxxx-6-xxxxxxxxxxxxxxx-4-xx)xxxxxxxxxxxx
|
535-89-7
|
208-622-6
|
613-004-00-8
|
|
Xxxxxxx (XXX); X-(3-xxxxx-4-xxxxxx-2-xxx-2X-xxxxxxx-7-xx)-X,X-xxxxxxx-xxxxxxxxxxxxx
|
56-72-4
|
200-285-3
|
015-038-00-3
|
|
Xxxxxxxxxxxx; 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naflyl)-2H-chromen-2-on
|
5836-29-3
|
227-424-0
|
607-059-00-7
|
|
Kyanid xxxxxxxxx
|
542-83-6
|
208-829-1
|
048-004-00-1
|
|
Xxxxxx xxxxxxxx
|
592-01-8
|
209-740-0
|
020-002-00-5
|
|
Xxxxxxx (x xxxxxxxx xxxxxxxxxxx xxxxxxx xxxx např. xxxxx- x xxxxxxxxxxxx x xxxxxx-xxxxx xxxxxxxxxx)
|
-
|
-
|
006-007-00-5
|
|
Xxxxxxxxxx
|
74-90-8
|
200-821-6
|
006-006-00-X
|
|
Xxxxxxxxxx ...%; xxxxxxxx xxxxxxxxxxxxx
|
74-90-8
|
200-821-6
|
006-006-01-7
|
|
Xxxxxxxxx (XXX); X,X-xxxxxxx-X-{[X-(1-xxxx-1-xxxxxxxxxxx)xxxxxxxxx]xxxxxx}-xxxxxxxxxxxxx
|
3734-95-0
|
223-099-4
|
015-070-00-8
|
|
Xxxxxxxx xxxxxxxxxxxxxx ... %
|
7664-39-3
|
231-634-8
|
009-003-00-1
|
|
Xxxxxxxxxx (ISO); diethyl-[N-(4-methyl-2H-1,3-dithiolan-2-yliden)fosforamidát]
|
950-10-7
|
213-447-3
|
015-094-00-9
|
|
Methamidofos (XXX); O,S-dimethyl-fosforamidothioát
|
10265-92-6
|
233-606-0
|
015-095-00-4
|
|
Methidathion (ISO); X-(5-xxxxxxx-2(3X)-xxx-4,5-xxxxxxx-1,3,4-xxxxxxxxxx-3-xx)-X,X-xxxxxxxx-xxxxxxxxxxxxxxx
|
950-37-8
|
213-449-4
|
015-069-00-2
|
|
Xxxxxxxx (XXX); xxxxxx-[X-(xxxxxxxxxxxxxxxxxx)xxxxxxxxxxxxxx]
|
16752-77-5
|
240-815-0
|
006-045-00-2
|
|
4-Xxxxxxxxxxxxx: x-xxxxxxxx
|
104-94-9
|
203-254-2
|
612-112-00-2
|
|
Xxxxxx-xxxxxxxxxxxx
|
79-22-1
|
201-187-3
|
607-019-00-9
|
|
Xxxxxx-xxxxxxxxx
|
624-83-9
|
210-866-3
|
615-001-00-7
|
|
Xxxxxxxx-xxxxxxxxxxxx
|
6317-18-6
|
228-652-3
|
615-020-00-0
|
|
Xxxxxxxx (XXX); xxxxxx-3-(xxxxxxxxxxxxxxxxxxxx)xxx-2-xxxxx; 2-(xxxxxxxxxxxxxxx)-1-xxxxxxxxxxx-xxxxxxxx-xxxxxx
|
7786-34-7
|
232-095-1
|
015-020-00-5
|
|
Xxxxxxxxxx (ISO); 4-dimethylamino-3,5-dimethylfenyl-N-methylkarbamát
|
315-18-4
|
206-249-3
|
006-054-00-1
|
|
Mipafox (XXX); xxxxxxx kyseliny X,X'-xxxxxxxxxxxxxxxxxxxxxxxxxxx
|
371-86-8
|
206-742-3
|
015-062-00-4
|
|
Xxxxxxxxxxxx (XXX); (X)-X-xxxxxx-3-(xxxxxxxxxxxxxxxxxxxx)xxx-2-xxxxxx
|
6923-22-4
|
230-042-7
|
015-072-00-9
|
|
Xxxxxxx (XXX); 3-(1-xxxxxxxxxxxxxxxx-2-xx)xxxxxxx
|
54-11-5
|
200-193-3
|
614-001-00-4
|
|
Xxxxxxx, soli; 3-(1-xxxxxxxxxxxxxxxx-2-xx)xxxxxxx, xxxx
|
-
|
-
|
614-002-00-X
|
|
2-Xxxxx-x-xxxxxxxx; 4-xxxxxxx-2-xxxxxxxxxxx
|
96-96-8
|
202-547-2
|
612-038-00-0
|
|
Xxxxxxxxxxxxx; xxxxxxxx-xxxxxxxxx
|
55-63-0
|
200-240-8
|
603-034-00-X
|
|
X-Xxxxxxxxxxxxxxxxxxx
|
62-75-9
|
200-549-8
|
612-077-00-3
|
|
Xxxxxx (XXX); {[2-dimethylamino-1-(methylsulfanyl)-2-oxoethiliden]iminyl}-N-methylkarbamát
|
23135-22-0
|
245-445-3
|
006-059-00-9
|
|
Oxid xxxxxxxx
|
1327-53-3
|
215-481-4
|
033-003-00-0
|
|
Xxxx beryllnatý
|
1304-56-9
|
215-133-1
|
004-003-00-8
|
|
Oxid dusičitý
|
10102-44-0
|
233-272-6
|
007-002-00-0
|
|
Oxid xxxxxxxx, xxxxx
|
10544-72-6
|
234-126-6
|
007-002-00-0
|
|
Xxxx xxxxxxxxxx
|
10049-04-4
|
233-162-8
|
017-026-00-3
|
|
Xxxx xxxxxxxx
|
1333-82-0
|
215-607-8
|
024-001-00-0
|
|
Xxxx xxxxxxxxx (nepyroforický)
|
1306-19-0
|
215-146-2
|
048-002-00-0
|
|
Oxid xxxxxxxx
|
20816-12-0
|
244-058-7
|
076-001-00-5
|
|
Xxxxxxxxxxxxx (XXX); X,X-xxxxxxx-X-[2-(xxxxxxxxxxxxx)xxxxx]-xxxxxxxxxxxxx
|
2497-07-6
|
219-679-1
|
015-096-00-X
|
|
Xxxxxxxx-xxxxxxxxx; 1,1'-xxxxxxxx-4,4'-xxxxxxxxx-1,1'-xxxxx-xxxxxxxxx
|
1910-42-5
|
217-615-7
|
613-090-00-7
|
|
Xxxxxxxx-xxxxxxxx sulfát; 1,1'-dimethyl-4,4'-bipyridin-1,1'-diium-bis(methyl-sulfát)
|
2074-50-2
|
218-196-3
|
613-090-00-7
|
|
Parathion (XXX); X,X-xxxxxxx-X-(4-xxxxxxxxxx)-xxxxxxxxxxxxx
|
56-38-2
|
200-271-7
|
015-034-00-1
|
|
Xxxxxxxxx-xxxxxx (XXX); X,X-xxxxxxxx-X-(4-xxxxxxxxxx)-xxxxxxxxxxxxx
|
298-00-0
|
206-050-1
|
015-035-00-7
|
|
Xxxxxxxxxxxxxxx
|
87-86-5
|
201-778-6
|
604-002-00-8
|
|
Xxxxxxxxxxxxxxxxx draselný; xxxxxxxxxxxxxxx, xxxxxxxxx soli
|
7778-73-6
|
231-911-3
|
604-003-00-3
|
|
Pentachlorfenolát xxxxx; xxxxxxxxxxxxxxx, alkalické xxxx
|
131-52-2
|
205-025-2
|
604-003-00-3
|
|
Xxxxxxxxxx; 2-xxxxx-3-[(1-xxxxxxxxxxxxxx-5-xx)xxxxxx]xxxxxx-4-xxxxxx
|
92-13-7
|
202-128-4
|
614-016-00-6
|
|
Xxxxxxxxxx, xxxx; 2-ethyl-3-[(1-methylimidazol-5-yl)methyl]butano-4-lakton, xxxx
|
-
|
-
|
614-017-00-1
|
|
Xxxxxxx; O,O-diethyl-O-(4-methyl-2-oxo-2H-chromen-7-yl)-fosforothioát
|
299-45-6
|
-
|
015-076-00-0
|
|
Produkt xxxxxx xxxxxxxx glutamové x X-xxxxx(X12-X14)xxxxxx-1,3-xxxxxxx
|
-
|
403-950-8
|
607-216-00-X
|
|
Xxxxxxx-3-xxxxxx;β-xxxxxxxxxxxx
|
57-57-8
|
200-340-1
|
606-031-00-1
|
|
Xxxxxxxxxxxx; 2-xxxxxxxxxxxxxx
|
75-55-8
|
200-878-7
|
613-033-00-6
|
|
Xxxxxxxx (ISO); X,X-xxxxxxx-(xxxxxxxxxxxxxxxxxx)xxxxxx-xxxxxxxxxxxxxxx
|
2275-18-5
|
218-893-2
|
015-032-00-0
|
|
Xxxxxxxxx; xxxxxxx-(3-xxxxxxxxxxxxx-5-xx)-xxxxxx
|
108-34-9
|
-
|
015-023-00-1
|
|
Xxxx, anorganické xxxxxxxxxx (s xxxxxxxx xxxxxxx xxxxxxxxxx)
|
-
|
-
|
080-002-00-6
|
|
Xxxx
|
7439-97-6
|
231-106-7
|
080-001-00-0
|
|
Xxxxx, organické xxxxxxxxxx
|
-
|
-
|
080-004-00-7
|
|
Xxxxxxxxxxx; 6β-xxxxxxx-3β-(β-X-xxxxxxxxxxxxxxxxx)-8,14-xxxxxxxxx-5 β-bufa-4,20,22-trienolid,
|
507-60-8
|
208-077-4
|
614-027-00-6
|
|
Seleničitan xxxxx
|
10102-18-8
|
233-267-9
|
034-003-00-3
|
|
Xxxxxxxx (XXX); oktamethyldifosforotetramid
|
152-16-9
|
205-801-0
|
015-026-00-8
|
|
Síran xxxxxxxxx
|
10124-36-4
|
233-331-6
|
048-009-00-9
|
|
Xxxxx xxxxxxx
|
7446-18-6
|
231-201-3
|
081-003-00-4
|
|
Xxxxxxxxxx; xxxxxxx; (6,7-xxxxx-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-3-xx)-2-xxxxx-3- xxxxxxxxxxxxxxxx
|
51-34-3
|
200-090-3
|
614-014-00-5
|
|
Xxxxxxxxxx, xxxx; (6,7-xxxxx-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-3-xx)-2-xxxxx-3- xxxxxxxxxxxxxxxx, xxxx
|
-
|
-
|
614-015-00-0
|
|
Xxxx: xxx- x trans-4-hydroxy-3-[3-(4-{[4-(trifluormethyl)benzyl]oxy} xxxxx)-1,2,3,4-xxxxxxxxxx-1-xxxxxx]xxxxxxx; xxxx: xxx- x xxxxx-4-xxxxxxx-3-[3-(4- {[4-(xxxxxxxxxxxxxx)xxxxxx]xxx}xxxxx)-1,2,3,4-xxxxxxxxxx-1-xxxxxx]-2X-xxxxxxx-2-xx
|
90035-08-8
|
421-960-0
|
607-375-00-5
|
|
Xxxxxxxxx; xxxxxxxxxxx-10-xx
|
57-24-9
|
200-319-7
|
614-003-00-5
|
|
Xxxxxxxxx, soli; xxxxxxxxxxx-10-xx, xxxx
|
-
|
-
|
614-004-00-0
|
|
Xxxxxx; xxxxxxxxx
|
7783-06-4
|
231-977-3
|
016-001-00-4
|
|
Xxxxxxxx (XXX); X,X,X,X-xxxxxxxxxx-xxxxxxxxxxxxxxxxx
|
3689-24-5
|
222-995-2
|
015-027-00-3
|
|
XXXX (XXX); xxxxxxxxxx-xxxxxxxx; xxxxxxxxxxxxxxxxxxxx
|
107-49-3
|
203-495-3
|
015-025-00-2
|
|
Xxxxxxxx (XXX); X-(xxxx-xxxxxxxxxxxxx)xxxxxx-X,X-xxxxxxx-xxxxxxxxxxxxxxx
|
13071-79-9
|
235-963-8
|
015-139-00-2
|
|
1,1,2,2-Xxxxxxxxxxxxxx
|
79-27-6
|
201-191-5
|
602-016-00-9
|
|
4,4,5,5-Xxxxxxxxxx-1,3-xxxxxxxx-2-xx
|
22432-68-4
|
404-060-2
|
602-075-00-0
|
|
1,1,2,2-Xxxxxxxxxxxxxxx
|
79-34-5
|
201-197-8
|
602-015-00-3
|
|
Xxxxxxxxxxxx xxxxx
|
13463-39-3
|
236-669-2
|
028-001-00-1
|
|
Xxxxxxxx
|
7440-28-0
|
231-138-1
|
081-001-00-3
|
|
Xxxxxxxx, xxxxxxxxxx
|
-
|
-
|
081-002-00-9
|
|
Xxxxxxxxx (XXX); 3,3-xxxxxxxx-1-(xxxxxxxxxxxxxx)xxxxx-2-xx-X-(X-xxxxxxxxxxxxxxx) ozim
|
39196-18-4
|
254-346-4
|
006-064-00-6
|
|
Tolylfluanid (ISO); X-[(xxxxxxxxxxxxxxxxxx)xxxxxxxx]-X',X'-xxxxxxxx-X-(4-xxxxxxxxxxx)xxxxxxxxxx
|
731-27-1
|
211-986-9
|
613-116-00-7
|
|
Xxxxxxxxxxxx thalný; xxxxxxxxxxxxxxxxx
|
3535-84-0
|
222-571-7
|
615-031-00-0
|
|
Xxxxxxxxx; X,X-xxxxxxx-X-xxxxxxx-2-xx-xxxxxxxxxxxxxxx
|
297-97-2
|
206-049-6
|
015-112-00-5
|
|
Xxxxxxxxx (XXX); 2-[xxx(xxxxxxxxxxxxx)xxxxxxxx]-5-xxxxx-2X-1,2,4-xxxxxxx-3-xxxx
|
1031-47-6
|
-
|
015-024-00-7
|
|
Xxxxxxxxxxxxxxx, xxxxxxxxxx
|
-
|
-
|
050-006-00-2
|
|
Xxxxxxxxxx xxxxxxxxx
|
10025-87-3
|
233-046-7
|
015-009-00-5
|
|
Xxxxxxxxxxxxxxxxxxx; xxxxxxxxxxx
|
76-06-2
|
200-930-9
|
610-001-00-3
|
|
2,4,6-Xxxxxxxx-1,3,5-xxxxxxx; xxxxxxxxxxxxx
|
108-77-0
|
203-614-9
|
613-009-00-5
|
|
Xxxxxxxxxxxx (ISO); X-xxxxx-X-(2,4,5-xxxxxxxxxxxxx)-xxxxxxxxxxxxxxxxxxx
|
327-98-0
|
206-326-1
|
015-098-00-0
|
|
Xxxxxxxxxxxxxxxx, xxxxxxxxxx
|
-
|
-
|
050-005-00-7
|
|
1,3,5-Xxxxxxxxxxxxxx
|
99-35-4
|
202-752-7
|
609-005-00-8
|
|
Xxxx
|
7440-61-1
|
231-170-6
|
092-001-00-8
|
|
Xxxx, xxxxxxxxxx
|
-
|
-
|
092-002-00-3
|
|
Xxxxx (XXX); xxxx-X,X-xxxxxxxxxxxxxxxxxxxxxx
|
137-30-4
|
205-288-3
|
006-012-00-2
|
Původní xxxxx - xxxxxxxx xx 1.1.2010 xx 4.1.2012 (xx xxxxxx č. 4/2012 Xx.)
Xxxxxxx x. 2 x xxxxxxxx vlády x. 467/2009 Sb.
Hodnoty xxxxxxxx látek, psychotropních xxxxx a xxxxxxxxx xx obsahujících a xxx účely xxxxxxxxx xxxxxxxx
X xxxxxxxxxxx xxxxxxx xxxx xxxxxxx v xxxxxxxxx sloupci vpravo xxxxxxxx xxxxxxxx xxxxxx xxxxx xx xxxxx xxxxx xxxx, xxx xxxx xxx xxxxxxxx xx směsi, xxxxxxxxxx xxxx hmotností "množství xxxxx xxx malé" xxxx xxxxx, xxxxxxxxxxxxx xxxxx xxxxxxx xxxxxx. Xxxxx je xxxxx xxxxxxxx xx xxxxx xxxx, xxxxx pro xxxxxx xxxxxx 'xxxxxxxxxx xxxxxxxx množství, xxx xxxx xxx xxxxxxxx xx xxxxx, xxxxxxxxxx xxxx hmotností "xxxxxxxx xxxxx než xxxx" xxxx xxxxx, specifikované xxxxx obecným xxxxxx' xxxxxxxxxx xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxx.
X některých xxxxxxxxx je xxx xxxxxx xxxxxxxxx xxxxxxx xxxxx v xxxxxxx xxxxxxxx xxxxxxxxxxxxx soli.
|
Typ xxxxx (xxxxxx vžitý xxxxx; "xxx drogy")
|
Mezinárodní xxxxxxxxxx xxxxx (XXX) x českém jazyce
|
množství xxxxx xxx xxxx
|
xxxxxx xxxxxxxxxxxx látka
|
nejmenší xxxxxxxx xxxxxx xxxxxxxxxxxx xxxxx, xxx musí xxxxxxxxx xxxxx, xxxxxxxx xxxx xxxxx, aby bylo xxxx xxxxxxxx množství xxxxxxxxxx xx xxxxx xxx malé
|
|
Pervitin
|
Metamfetamin
|
více xxx 2 g
|
(+)-1-fenyl-2-methylaminopropan
|
0,6 x
0,72 x
(xxxxxxxxxxxx)
|
|
Xxxxxx
|
Xxxxxx
|
&xxxx;
xxxx xxx 1,5 x
|
&xxxx;
3,6-xxxxxxxxxxxxxx
|
&xxxx;
0,2x
0,22 x
(xxxxxxxxxxxx)
|
|
Xxxxxx
|
Xxxxxx
|
&xxxx;
xxxx xxx 1 x
|
&xxxx;
xxxxxxxxxxx xxxxxxxxxxxxxxx
|
&xxxx;
0,54 x
0,6 g (hydrochlorid)
|
|
Amfetamin (xxxxxxxxx)
Xxxxxxxxxxxx (xxxxxxxx)
|
Xxxxxxxxx
|
&xxxx;
xxxx xxx 2 x
|
&xxxx;
(+/-)-2-xxxxx-1-xxxxxxxxxxx
(+)-2-xxxxx-1-xxxxxxxxxxx
|
&xxxx;
0,73 x
1,0 x (xxxxxx)
|
|
Xxxxxxxx
|
&xxxx;
0,05 x
|
&xxxx;
X-(1-xxxxxxxx-4-xxxxxxxxx)xxxxxxxxxxxxx
|
&xxxx;
0,032 x
0,05 x (xxxxxx)
|
|
|
Xxxxxx (XXXX)
|
3,4-Xxxxxxxx- xxxxx- xxxxxxxxxxxxx
|
&xxxx;
xxxx xxx 4 xxxxxxx/xxxxxx xxxx xxxx než 0,4 x xxxxxxxxxx xx xxxxxxxxxxx xxxxxxxxx
|
&xxxx;
1-(3,4-xxxxxxxxxxxxxxxxxx)- 2-xxxxxxxxxxxxxxxxx
|
&xxxx;
0,34 x
0,40 x (xxxxxxxxxxxx)
|
|
Xxxxxx (XXX)
|
Xxxxxxxxxxxx
|
&xxxx;
xxxx xxx 4 tablety/kapsle nebo xxxx než 0,4 x xxxxxxxxxx xx xxxxxxxxxxx xxxxxxxxx
|
&xxxx;
2-xxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx) xxxxxx
|
&xxxx;
0,33 x
0,40 x (xxxxxxxxxxxx)
|
|
Xxxxxx (XXXX)
|
X-Xxxxx MDA
|
více než 4 xxxxxxx/xxxxxx nebo xxxx xxx 0,4 x xxxxxxxxxx či xxxxxxxxxxx substance
|
((+/-)-N-ethyl-alfa-methyl-3,4- (xxxxxxxxxxxxx)xxxxxxxxxxxx),
|
&xxxx;
0,34 x
0,40 g (xxxxxxxxxxxx)
|
|
4-XXX
|
4-XXX
|
&xxxx;
xxxx xxx 4 tablety/kapsle xxxx xxxx xxx 0,4 x práškovité xx xxxxxxxxxxx xxxxxxxxx
|
&xxxx;
2-xxxxx-1-(4-xxxxxxxxxxxxxxx)xxxxxx
|
&xxxx;
0,20 x
|
|
XXX
|
xxxx-xxxxxx- amfetamin
|
více než 4 xxxxxxx/xxxxxx xxxx xxxx xxx 0,4 x práškovité xx xxxxxxxxxxx xxxxxxxxx
|
&xxxx;
2-xxxxx-1-(4-xxxxxxxxxxxx)xxxxxx
|
&xxxx;
0,30 g
|
|
PMMA
|
para-metoxy- xxxxxxxxxxxx
|
&xxxx;
xxxx xxx 4 xxxxxxx/xxxxxx xxxx více xxx 0,4 x xxxxxxxxxx xx xxxxxxxxxxx xxxxxxxxx
|
&xxxx;
1-(4-xxxxxxxxxxxx)-2- (methylamino)propan
|
0,50 g
|
|
2C-B
|
více xxx 4 tablety/kapsle xxxx xxxx než 0,4 x xxxxxxxxxx xx krystalické xxxxxxxxx
|
&xxxx;
4-xxxxx-2,5- xxxxxxxxxxxxxxxxxxxxx
|
&xxxx;
0,20 x
|
|
|
2X-X
|
&xxxx;
xxxx xxx 4 xxxxxxx/xxxxxx nebo xxxx xxx 0,4 x xxxxxxxxxx xx xxxxxxxxxxx xxxxxxxxx
|
&xxxx;
4-xxxx-2,5-xxxxxxxxxxxxxxxxxxxxx
|
&xxxx;
0,20 x
|
|
|
XXX,
Xxxxxxxxxxxxxx
|
Xxxxxxxxxxxxx
|
&xxxx;
xxxx xxx 4 xxxxxxx/xxxxxx xxxx xxxx xxx 0,4 x xxxxxxxxxx xx krystalické xxxxxxxxx
|
&xxxx;
2-xxxxx-1-(4-xxxx-2,5- xxxxxxxxxxxxxx)xxxxxx
|
&xxxx;
0,015 g
|
|
STP, DOM
|
více xxx 4 xxxxxxx/xxxxxx xxxx xxxx než 0,40 x práškovité xx krystalické xxxxxxxxx
|
&xxxx;
2-xxxxx-1-(2,5-xxxxxxxxx-4- xxxxxxxxxxx)xxxxxx
|
&xxxx;
0,015 x
|
|
|
2X-X-2
|
&xxxx;
xxxx než 4 tablety/kapsle xxxx xxxx xxx 0,40 x xxxxxxxxxx xx xxxxxxxxxxx substance
|
2,5-dimethoxy-4-etylthiofenetylamin
|
0,100 x
|
|
|
2X-X-7
|
&xxxx;
xxxx xxx 4 xxxxxxx/xxxxxx xxxx xxxx xxx 0,40 x xxxxxxxxxx xx xxxxxxxxxxx xxxxxxxxx
|
&xxxx;
2,5-xxxxxxxxx-4-(x)- xxxxxxxxxxxxxxxxxxxxx
|
&xxxx;
0,100 x
|
|
|
XXX
|
&xxxx;
xxxx xxx 4 tablety/kapsle xxxx 0,80 x xxxxxxxxxx xx xxxxxxxxxxx xxxxxxxxx
|
&xxxx;
X,X-xxxxxxxxxxxxxxxx
|
&xxxx;
0,200 x
|
|
|
XXX
|
Xxxxxxxxxxx- fetamin
|
více xxx 4 tablety/kapsle nebo 1 g práškovité xx krystalické xxxxxxxxx
|
&xxxx;
xx-2-xxxxx-1-(2,5-xxxxxxxxxxxxxx) xxxxxx
|
&xxxx;
0,400 x
|
|
XXXX
|
2,5-xxxxxxxxx-4- xxxxxxxxxxxxxxx
|
&xxxx;
xxxx xxx 4 tablety/kapsle xxxx 0,120 x xxxxxxxxxx xx xxxxxxxxxxx xxxxxxxxx
|
&xxxx;
xx-2-xxxxx-1-(2,5-xxxxxxxxx-4- xxxxxxxxxx)xxxxxx
|
&xxxx;
0,030 g
|
|
AET, Xxxxxx
|
Xxxxxxxxxx
|
&xxxx;
xxxx xxx 4 xxxxxxx/xxxxxx nebo 0,80 x práškovité xx xxxxxxxxxxx xxxxxxxxx
|
&xxxx;
3-(2-xxxxxxxxxx)xxxxx
|
&xxxx;
0,200 x
|
|
Xxxxxx (XXXX)
|
5-Xxxxxxx-3,4- methylendioxy -xxxxxxxxx
|
&xxxx;
xxxx xxx 4 tablety/kapsle xxxx 1,2 x xxxxxxxxxx xx xxxxxxxxxxx xxxxxxxxx
|
&xxxx;
2-xxxxx-1-(5-xxxxxxx-3,4- xxxxxxxxxxxxxxxxxx)xxxxxx,
|
&xxxx;
0,300x
|
|
XXX
|
Xxxxxxxxxx- xxxxxxxxx
|
&xxxx;
xxxx xxx 4 xxxxxxx/xxxxxx xxxx 0,50 x xxxxxxxxxx xx xxxxxxxxxxx xxxxxxxxx
|
&xxxx;
xx-2-xxxxx-1-(3,4,5-xxxxxxxxxxxxxxx) propan
|
0,300g
|
|
TMA-2
|
více xxx 4 xxxxxxx/xxxxxx xxxx 0,20 x xxxxxxxxxx xx xxxxxxxxxxx xxxxxxxxx
|
&xxxx;
xx-2-xxxxx-1-(2,4,5-xxxxxxxxxxxxxxx) xxxxxx
|
&xxxx;
0,080x
|
|
|
Xxxxxxxxxxxx
|
&xxxx;
xxxx xxx 4 xxxxxxx/xxxxxx nebo 0,80g xxxxxxxxxx xx xxxxxxxxxxx xxxxxxxxx
|
&xxxx;
2-(xxxxxxxxxxx)-1-xxxxxxxxxxx-1-xx
|
&xxxx;
0,200x
|
|
|
XXX
|
&xxxx;
xxxx xxx 0,60 x práškovité či xxxxxxxxxxx xxxxxxxxx, 0,5 x xxxxxx Ayahuasca
|
N,N-dimethyltryptamin
|
0,150 x
|
|
|
XXX (LSD-25, (+)Xxxxxxxx)
|
XXX
XXX-25
|
&xxxx;
5 xxxxxxx, tablet, xxxxxxxxxxxx xxxxxx xxxx "krystalů" xxxxxxxxxxxxxx účinnou xxxxxx
|
&xxxx;
(+)-X,X-xxxxxxxxxxxxxxxxx (xxxxxxxxxxx kyseliny x-xxxxxxxxx)
|
&xxxx;
0,000134 x
0,000250 x (xxxxxxxx)
|
|
Xxxxxxxxxxxxx (XXX)
|
Xxxxxxxxxxx
|
&xxxx;
50 xx olejnaté xxxxxxxx 1 g xxxxxxxx nebo prášku, xxxx než 4 xxxxxx/xxxxxx
|
&xxxx;
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxx
|
&xxxx;
0,020 g
|
|
Desomorfin
|
Desomorfin
|
2 x xxxxxxxxxxx látky
|
6-desoxy-7,8-dihydromorfin
|
0,500 g
|
|
Etorfin
|
Etorfin
|
5 xx xxxxxxxxxxx xxxxx, xxxx xxxx. 1 xxxxxxxx xxxxxxxxx xxx xxxxxxxxxxx užití (např. Xxxxxxxxx)
|
&xxxx;
6,7,8,14-xxxxxxxxxx-7xxxx-2(X)- xxxxxxx-2-xxxxxx-6,14-xxxx- xxxxxxxxxxxxxx
|
&xxxx;
0,000100 x
|
|
Xxxxxxxxxxx
|
Xxxxxxxxxxx
|
&xxxx;
xxxx než 1 xxxx xxxxxxxxxxx xxxxx xxxx 20 tbl x 5 mg, 10 xxxxxx x 10 mg nebo 20 ampulí x 5 xx xxx xxxxxxxx aplikaci (Xxxxxxxx, Xxxxxxx, Xxxxxxx, Xxxxxxx, Xxxxxxx...)
|
&xxxx;
4-(3-xxxxxxxxxxxx)-1-xxxxxx-4- xxxxxxxxxxxxxxxxxx
|
&xxxx;
0,100 xx
|
|
4-Xxxxxxxxxxxxxx
|
4-Xxxxxxxxxxxxxx
|
&xxxx;
0,5 x xxxxxxxx nebo xxxxxx, více xxx 4 xxxxxx/xxxxxx
|
&xxxx;
(+/-)-xxx-2-xxxxx-5-xxxxx-4-xxxxxx-2- xxxxxxxx
|
&xxxx;
0,100x
|
|
XXXX
|
&xxxx;
1 x krystalů xxxx xxxxxx
|
&xxxx;
3-(1,2-xxxxxxxxxxxxxx)-1-xxxxxxx- 7,8,9,10-xxxxx-xxxxx-6,6,9-xxxxxxxxx- 6X-xxxxxxxx,xxxxxx
|
&xxxx;
0,200 x
|
|
|
X-Xxxxxxx XXX
|
X-Xxxxxxx XXX
|
&xxxx;
1 x krystalů xxxx xxxxxx, více xxx 4 tablet/kapslí
|
+/-)-N[alfa-methyl-3,4-(methylendioxy) fenethyl]hydroxylamin
|
0,500g
|
|
Parahexyl
|
1 x krystalů xxxx xxxxxx
|
&xxxx;
3-xxxxx-1-xxxxxxx-7,8,9,10-xxxxxxxxxx -6,6,9-xxx-xxxxxx-6X- xxxxxxxx[x,x]xxxxx
|
&xxxx;
0,200 x
|
|
|
Xxxxxxxxxxxx (PHP, XXXX)
|
Xxxxxxxxxxxx
|
&xxxx;
1 x krystalů xxxx xxxxxx, xxxx xxx 4 tablet/kapslí
|
1-(1-fenylcyklohexyl)pyrrolidin
|
0,020 g
|
|
Tenocyklidin (XXX)
|
Xxxxxxxxxxxx
|
&xxxx;
1 x xxxxxxxx xxxx xxxxxx, xxxx xxx 4 tablet/kapslí
|
1-1-(2-thienyl)cyklohexylpiperidin
|
0,010 x
|
|
Xxxxxxxxx
|
Xxxxxx
|
&xxxx;
xxxx xxx 15 xxxxx sušiny
|
delta-9-tetrahydrocannabinol
|
1,5 x
|
|
Xxxxx
|
Xxxxxxxxxx x konopí
|
více než 5 xxxxx
|
&xxxx;
xxxxx-9-xxxxxxxxxxxxxxxxxxxx
|
&xxxx;
1 x
|
|
Xxxxxxxxxx x xxxxx xxxxx xxxxxxxxxx xxxxxxxx a/nebo xxxxxxxxxx (xxxxxxxx)
|
Xxxxxxxx
Xxxxxxxxxx
|
&xxxx;
Xxxx xxx 40 plodnic xxxxx
|
&xxxx;
Xxxxxxxx: 3-(2-xxxxxxxxxxxxxxxxxx)- 4-hydroxyindol).
Psilocybin: X,X-xxxxxxxx-0-xxxxxxxx- 4-xxxxxxxxxxxxxxxx,
|
&xxxx;
0,05 x báze (xxxxxxxxx) nebo xxxxxxxxxxxx xxxxxxxx xxxxxxxxxxx (xxxxxxxxxxx xxxxxx xxxxxxxxx)
|
|
Xxxxxxxxxx x xxxxx xxxxx obsahující xxxxxxxx x/xxxx xxxxxxxxxx (xxxxxxxx)
|
Xxxxxxxx
Xxxxxxxxxx
|
&xxxx;
Xxxx xxx 40 xxxxx xxxxx (nebo xxxx xxxxx půdy) x xxxxxxxx
|
&xxxx;
Xxxxxxxx: 3-(2-dimethylaminoethyl)- 4-xxxxxxxxxxxx).
Xxxxxxxxxx: N,N-dimethyl-0-fosforyl- 4-hydroxytryptamin,
|
0,05 x xxxx (psilocinu) xxxx odpovídající xxxxxxxx xxxxxxxxxxx (fosfátového xxxxxx xxxxxxxxx)
|
|
Xxxx
|
Xxxxxxxx
|
&xxxx;
80 g xxxxxxxxx xxxxxxxxxxx xxxxxxxxx
|
&xxxx;
()-2-xxxxxxxxxxxxxxxx
|
&xxxx;
4 x
|
|
Xxxxxxxx
|
Xxxxxxxx
|
&xxxx;
200 x xxxxxxx xxxxxxxxx xxxxx xxxx 25 x sušiny xxxxxxx xxxx Xxxxxxxxx Williamsi, Xxxxxxxxxx xxxxxxxx, Xxxxxxxxxx xxxxxxxx, Trichocereus xxxxxxxxx; xxxxxxxxxx; fulvinanus; xxxxxxxx.
|
&xxxx;
3,4,5-xxxxxxxxxxxxxxxxxxxxxx
|
&xxxx;
0,75 x
|
|
Xxxxxxxxxx
|
Xxxxxxxxxx
|
&xxxx; | &xxxx;
2,2-xxxxxxx-4-[4-(3-xxxxxxxxx-2-xxx-2,3- xxxxxxxxxxxxxxxxxxx-1-xx) piperidino]butyronitril
|
105 xx
|
|
Xxxxxxxxxxxxx
|
Xxxxxxxxxxxxx
|
&xxxx; | &xxxx;
1-[(3X)-2,2-xxxxxxx-3-xxxxxx-4- (morfolin-4-yl)butanoyl]pyrrolidin
|
280 mg
|
|
Difenoxylát
|
Difenoxylát
|
Ethyl-4-fenyl-1-(3,3- xxxxxxx-3- xxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx
|
&xxxx;
105 xx
|
|
|
Xxxxxxxxx
|
Xxxxxxxxx
|
&xxxx; | &xxxx;
(2XX,6X,11X)-6,11-xxxxxxxx-3- xxxxxxxx-1,2,3,4,5,6- xxxxxxxxx-2,6- xxxxxxx-3-xxxxxxxxxx-8-xx
|
&xxxx;
21 xx
|
|
Xxxxxxxx
|
Xxxxxxxx 1.2
|
N-fenyl-N-[1-(2-fenylethyl)piperidin- 4-yl]propanamid
|
8,4 xx
|
|
|
Xxxxxxxxxx
|
Xxxxxxxxxx
|
&xxxx; | &xxxx;
4,5α-xxxxx-3-xxxxxxx-17- xxxxxxxxxxxxxx-6-xx
|
&xxxx;
105 mg
|
|
Hydromorfon
|
Hydromorfon 20
|
&xxxx; | &xxxx;
4,5α-xxxxx-3-xxxxxxx-17- xxxxxxxxxxxxxx-6-xx
|
&xxxx;
140 xx
|
|
Xxxxxxxxxx
|
Xxxxxxxxxx
|
&xxxx; | &xxxx;
(4,5α-xxxxx-17-xxxxxxxxxxxxxx-7-xx- 3,6α-xxxx)xxxxxxxxxxx
|
&xxxx;
210 xx
|
|
Xxxxx
|
Xxxxx
|
&xxxx; | &xxxx; | &xxxx;
0,7 g
|
|
Oxykodon
|
Oxykodon 750130-X
|
&xxxx; | &xxxx;
(5X,9X,13X,14X)-14-xxxxxxx-3- xxxxxxx-17-xxxxxx-4,5- epoxymorfinan-6-on
|
525 xx
|
|
Xxxxxxxx
|
Xxxxxxxx
|
&xxxx; | &xxxx;
Xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4- karboxylát
|
2,8 x
|
|
Xxxxxxxxxx
|
Xxxxxxxxxx 45
|
&xxxx; | &xxxx;
1'-(3,3-xxxxxxx-3- kyanopropyl)-1,4'- bipiperidin-4'-karbamid
|
315 xx
|
|
Xxxxxxxx
|
Xxxxxxxx
|
&xxxx; | &xxxx;
[(5X,9X,13X,14X)-4,5-xxxxx-3- xxxxxxx-X-xxxxxxxxxxxx-6-xx-6-xx] acetát
|
105 xx
|
|
Xxxxxxx
|
Xxxxxxx
|
&xxxx; | &xxxx;
Xxxxx-(XXX,2XX)-2-(xxxxxxxxxxxxx)-1- fenylcyldohex-3-en-1-karboxylát
|
1,49
|
|
Acetyldihydro- xxxxxx
|
Xxxxxxxxxxxxx- xxxxxx
|
&xxxx; | &xxxx;
(4,5α-xxxxx-3-xxxxxxx-17- xxxxxxxxxxxxx-6α-xx)xxxxxx
|
&xxxx;
210 xx
|
|
Xxxxxxxxxxxxxxxx
|
Xxxxxxxxxxxxxxxx
|
&xxxx; | &xxxx;
[1X,2X-1-xxxxxx-3-(xxxxxxxxxxxxx)-1- xxxxx-2-xxxxxxxxxxxx]xxxxxxxxx
|
&xxxx;
1,4 x chlorid,
2,1 x xxxxxxxx
|
|
Xxxxxxxxxxxxx
|
Xxxxxxxxxxxxx
|
&xxxx; | &xxxx;
4,5α-xxxxx-3-xxxxxxx-17- methylmorfinan-6α-ol
|
1,05 x
|
|
Xxxxxx
|
Xxxxxx
|
&xxxx; | &xxxx;
7,8-xxxxxxxxx-4,5- xxxxx-17- xxxxxxxxxxxxxx-3,6-xxxx
|
&xxxx;
300 xx
390 xx (hydrochlorid)
|
|
Ethylmorfin
|
Ethylmorfin
|
4,5α-epoxy-3-ethoxy-17-methyl-7,8- xxxxxxxxxxxxxxxxx-6α-xx
|
&xxxx;
350 mg
|
|
|
Folkodin
|
Folkodin
|
4,5α-epoxy-3-ethoxy-17-methyl-3-[2- (morfolin-4-yl)ethoxy]-7,8- xxxxxxxxxxxxxxxxx-6α-xx
|
&xxxx;
350 mg
|
|
|
Kodein
|
Kodein 0.2-O
|
4,5α-epoxy-3-methoxy- 17-xxxxxx- 7,8-didehydromorfinan-6α-ol
|
0,7 x
|
|
|
Xxxxxxxxxxx (Xxxxxxx®, Suboxone®, atd.)
|
Buprenorfm
|
21-cyldopropyl-7-alfa-[(S)-1-hydro- 1,2,2-xxxxxxxxxxxxxxx]-6,14-xxxx- xxxxxx-6,7,8,14-xxxxxxxxxxxxxxxxxx
|
&xxxx;
52 xx
56 xx (hydrocholid)
|
|
|
Metadon
|
Methadon
|
4,4-difenyl-6-dimethylamino-3- xxxxxxxx
|
&xxxx;
500 xx
560 xx (hydrochlorid)
|
|
|
Dexamfetamin
|
Dexamfetamin
|
(S)-1-fenylpropan-2-yl xxxx
|
&xxxx;
105 xx
|
|
|
Xxxxxxxxxxxxx
|
Xxxxxxxxxxxxx
|
&xxxx; | &xxxx;
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-1,3- xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx
|
&xxxx;
7 xx
|
|
Xxxxxxxxxx (xxxxx Xxxxxxxxxxx)
|
Xxxxxxxxxx (xxxxx Methakvalon)
|
2-methyl-3-(2-methylfenyl)chinazolin- 4(3X)-xx
|
&xxxx;
1,4 x
|
|
|
Xxxxxxxxxxxxx
|
Xxxxxxxxxxxxx
|
&xxxx; | &xxxx;
Xxxxxx-(XX)-xxxxx-[(XX)-xxxxxxxxx-2-xx] xxxxxx
|
&xxxx;
210 xx
|
|
Xxxxxxxxxxxx
|
Xxxxxxxxxxxx
|
&xxxx; | &xxxx;
Xxxxxxxx 5-xxxxx-5-(1-xxxxxxxxxxx)xxxxxxxxxxx
|
&xxxx;
0,7 x
|
|
Xxxxxxxxxxx
|
Xxxxxxxxxxx
|
&xxxx; | &xxxx;
Xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxxx
|
&xxxx;
0,7 x
|
|
Xxxxxxxxxxxxx
|
Xxxxxxxxxxxxx
|
&xxxx; | &xxxx;
Xxxxxxxx 5-(1-xxxxxxxx-1-xx-1-xx )-5- xxxxxxxxxxxxxxxx
|
&xxxx;
1,4 x
|
|
Xxxxxxxxxxx
|
Xxxxxxxxxxx
|
&xxxx; | &xxxx;
(XX)-3-xxxxx-3-xxxxxxxxxxxxxx-2,6-xxxx
|
&xxxx;
1,75 g
|
|
Pentazocin
|
Pentazocin 0,2-X,X
|
&xxxx; | &xxxx;
(2XX,6XX,11XX)-6,11-xxxxxxxx-3-(3- xxxxxxxxx-2-xx-1-xx)-1,2,3,4,5,6- xxxxxxxxx-2,6-xxxxxxx-3- xxxxxxxxxx-8-xx
|
&xxxx;
1,4 g
|
|
Pentobarbital
|
Pentobarbital
|
5-ethyl-5-[(1RS)-1- xxxxxxxxxxx]xxxxxxxxx-2,4,6 (1X,3X,5X)xxxxx
|
&xxxx;
0,7 x
|
|
|
Xxxxxxxxxx
|
Xxxxxxxxxx
|
&xxxx; | &xxxx;
8-xxxxx-6-xxxxx-1-xxxxxx-4X-[1,2,4] xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx
|
&xxxx;
7 xx
|
|
Xxxxxxxxxx
|
Xxxxxxxxxx
|
&xxxx; | &xxxx;
2-(xxxxxxxxxxxx)-xxxxxxxxxxx-1-xx
|
&xxxx;
525 xx
|
|
Xxxxxxxx
|
Xxxxxxxx
|
&xxxx; | &xxxx;
5,5-xxxxxxxxxxxxxxxx-2,4,6(1X,3X,5X)- trion
|
3,5 x
|
|
Xxxxxxxxxx
|
Xxxxxxxxxx
|
&xxxx; | &xxxx;
7-xxxx-5-(xxxxxxx-2-xx)-1,3-xxxxxxx-2X- 1,4-xxxxxxxxxxxxx-2-xx
|
&xxxx;
70 xx
|
|
Xxxxxxxxxx
|
Xxxxxxxxxx
|
&xxxx; | &xxxx;
2-xxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X- xxxxxx[3,2-x] [1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxx
|
&xxxx;
1,75 mg
|
|
Butobarbital
|
Butobarbital
|
5-butyl-5-ethylpyrimidin- 2,4,6(1X,3X,5X)xxxxx
|
&xxxx;
1,05 x
|
|
|
Xxxxxxxxx
|
Xxxxxxxxx
|
&xxxx; | &xxxx;
8-xxxxx 6-xxxxx-4X-x- xxxxxxxx[4,3-x][1,4]-xxxxxxxxxxxxx
|
&xxxx; |
|
Xxxxxxxxxxxxx
|
Xxxxxxxxxxxxx
|
&xxxx; | &xxxx;
1-xxxxx-3-xxxxxxxxx-1-xx-4-xx-3-xx
|
&xxxx;
3,5 x
|
|
Xxxxx-xxxxxxxxxx
(xxxxx Xxxxxxxxxxxxxxx)
|
Xxxxx-xxxxxxxxxx (xxxxx Xxxxxxxxxxxxxxx)
|
&xxxx; | &xxxx;
Xxxxx-7-xxxxx-5-(2-xxxxxxxxxx)-2,3- xxxxxxx-2-xxx-1X-1,4-xxxxxxxxxxxxx- 3-xxxxxxxxxx
|
&xxxx;
14 mg
|
|
Fenobarbital
|
Fenobarbital
|
5-ethyl-5-fenylpyrimidin-2,4,6 (1H,3H,5H)trion
|
0,7 x
|
|
|
Xxxxxxxxx
|
Xxxxxxxxx
|
&xxxx; | &xxxx;
2-xxxxxxxxxxxx-2-xxxxxx
|
&xxxx;
105 xx
|
|
Xxxxxxxxxxx
|
Xxxxxxxxxxx
|
&xxxx; | &xxxx;
7-xxxxx-5-(2-xxxxxxxxxx)-7-1,3-xxxxxxx- 1-xxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx
|
&xxxx;
5,25 xx
|
|
Xxxxxxxxxx
|
Xxxxxxxxxx
|
&xxxx; | &xxxx;
7-xxxxx-1-[2-(xxxxxxxxxxxx)xxxxx]- 5-(2-fluorfenyl)- 1,3-dihydro-2H-1,4- xxxxxxxxxxxxx-2-xx
|
&xxxx;
210 mg
|
|
Halazepam
|
Halazepam
|
7-chlor -5-xxxxx-1-(2,2,2-xxxxxxxxxxxxx)- 1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx- 2-xx
|
&xxxx;
0,7 x
|
|
|
Xxxxxxxxxxxxxxx
|
Xxxxxxxxxxxxxxx
|
&xxxx; | &xxxx;
7-xxxxx-5-xxxxx-2-(xxxxxxxxxxx)-3X- 1,4-xxxxxxxxxxxxx-4-xxxx
|
&xxxx;
350 xx
|
|
Xxxxxxxxx
|
Xxxxxxxxx
|
&xxxx; | &xxxx;
[(XX)-7-xxxxx 2,3-xxxxxxx-5-xxxxx-1- xxxxxx-2-xxx-1X-1,4-xxxxxxxxxxxxx- 3-xx]xxxxxxxxxxxxxxxx
|
&xxxx;
210 xx
|
|
Xxxxxxxx
|
Xxxxxxxx
|
&xxxx; | &xxxx;
7-xxxxx-5-xxxxx-1-xxxxxx-1,5-xxxxxxx- 3X-1,5-xxxxxxxxxxxxx-2,4-xxxx
|
&xxxx;
140 xx
|
|
Xxxxxxxxxx
|
Xxxxxxxxxx
|
&xxxx; | &xxxx;
5-(2-xxxxxxxxxx)-7-xxxxx-1,3-xxxxxxx-2X- 1,4-xxxxxxxxxxxxx-2-xx
|
&xxxx;
56 xx
|
|
Xxxxxxxx
|
Xxxxxxxx
|
&xxxx; | &xxxx;
7xxxxx-5-xxxxx-1-xxxxxx-1,3-xxxxxxx- 2X-1,4-xxxxxxxxxxxxx-2-xx
|
&xxxx;
70 xx
|
|
Xxxxxxxx
|
Xxxxxxxx
|
&xxxx; | &xxxx;
(3XX)-7-xxxxx-5-xxxxx-3-xxxxxxx-2,3- xxxxxxx-1X-1,4-xxxxxxxxxxxxx-2-xx
|
&xxxx;
350 xx
|
|
Xxxxxxxxxxx xxxxxxxx (xxxxx Klorazepát)
|
Klorazepová xxxxxxxx (xxxxx Klorazepát)
|
Kyselina (3XX)-7-xxxxx-5-xxxxx-2-xxx- 2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3- karboxylová
|
140 xx
|
|
|
Xxxxxxxxxx
|
Xxxxxxxxxx
|
&xxxx; | &xxxx;
6-(2-xxxxxxxxxx)-2,4-xxxxxxx-2-[(X)-4- xxxxxxxxxxxxxxx-1-xxxxxxxxxx]-8-xxxxx- 1X-xxxxxxx[1,2-x] [1,4]xxxxxxxxxxxxx-1-xx
|
&xxxx;
7 xx
|
|
Xxxxxxxxx
|
Xxxxxxxxx
|
&xxxx; | &xxxx;
(3XX)-7-xxxxx-5-(2-xxxxxxxxxx)-3- xxxxxxx-2,3-xxxxxxx-1X-1,4- xxxxxxxxxxxxx-2-xx
|
&xxxx;
17,5 xx
|
|
Xxxxxxxx
|
Xxxxxxxx
|
&xxxx; | &xxxx;
(XX)-5-(4-xxxxxxxxxx)-2, 5-dihydro- 3H-imidazo[2,1-α]-isoindol-5-ol)
|
7 xx
|
|
Xxxxxxxxx
|
Xxxxxxxxx
|
&xxxx; | &xxxx;
7-xxxxx-5-xxxxx-2,3-xxxxxxx-1-xxxxxx- 1X-1,4-xxxxxxxxxxxxx
|
&xxxx;
140 xx
|
|
Xxxxxxxxxx
|
Xxxxxxxxxx
|
&xxxx; | &xxxx;
(2-xxxxxx-2-xxxxxxxxxxxx-1,3- xxxx)xxxxxxxxxx
|
&xxxx;
8,4 x
|
|
Xxxxxxxxxxxxxxxxxx
|
Xxxxxxxxxxxxxxxxxx
|
&xxxx; | &xxxx;
(XX)-5-xxxxx-5-xxxxx-1-xxxxxxxxxxxxxxx- 2,4,6(1X,3X,5X)xxxxx
|
&xxxx;
3,5 x
|
|
Xxxxxxxxxxx
|
Xxxxxxxxxxx
|
&xxxx; | &xxxx;
3,3-xxxxxxx-5-xxxxxxxxxxxxxxx-2,4-xxxx
|
&xxxx;
1,4 g
|
|
Midazolam
|
Midazolam
|
8-chlor-6-(2-fluorfenyl)-1-methyl- 4X-xxxxxxx [1,5-x] [1,4]xxxxxxxxxxxxx
|
&xxxx;
105 xx
|
|
|
Xxxxxxxxxx
|
Xxxxxxxxxx
|
&xxxx; | &xxxx;
5-xxxxx-7-xxxxx-1,3-xxxxxxx -2X-1,4- benzodiazepin-2-on
|
35 xx
|
|
Xxxxxxxxxx
|
Xxxxxxxxxx
|
&xxxx; | &xxxx;
7-xxxxx-5-xxxxx-2,3-xxxxxxx-1X-1,4- xxxxxxxxxxxxx-2-xx
|
&xxxx;
105 mg
|
|
Pemolin
|
Pemolin
|
(RS)-2-amino-5-fenyl-4,5- dihydrooxazol-4-on
|
280 xx
|
|
|
Xxxxxxxxx
|
Xxxxxxxxx
|
&xxxx; | &xxxx;
xxxxxxx(2-xxxxxxxxx)xxxxxxxx
|
&xxxx;
210 mg
|
|
Prazepam
|
Prazepam
|
7-chlor-1-(cyklopropylmethyl)-5-fenyl- 1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx- 2-xx
|
&xxxx;
210 mg
|
|
|
Temazepam
|
Temazepam
|
(3RS)-7-chlor-5-fenyl-3-hydroxy-1- methyl-2,3-dihydro-1H-1,4- xxxxxxxxxxxxx-2-xx
|
&xxxx;
140 mg
|
|
|
Triazolam
|
Triazolam
|
8-chlor-6-(2-chlorfenyl)-1-methyl- 4X-1,2,4-xxxxxxxx[4,3-x] [1,4]xxxxxxxxxxxxx
|
&xxxx;
1,75 xx
|
|
|
Xxxxxxxxxx
|
Xxxxxxxxxx
|
&xxxx; | &xxxx;
Xxxxxxxx (RS)-5-(1-methylbutyl)-5- xxxxxxxxxxxxxxxx
|
&xxxx;
1,05 x
|
|
Xxxxxxxx
|
Xxxxxxxx
|
&xxxx; | &xxxx;
X,X-xxxxxxxx-2-[6-xxxxxxxxx-2-(4- xxxxx)xxxxxxx[1,2-x]xxxxxxx-3- xx]xxxxxxxx
|
&xxxx;
70 xx
|
Informace
Xxxxxx předpis x. 467/2009 Sb. xxxxx xxxxxxxxx xxxx 1.1.2010.
Ve xxxxx xxxxxx xxxxxxxx předpisu xxxx xxxxxxxxxx xxxxx x xxxxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx x.:
4/2012 Sb., xxxxxx xx mění xxxxxxxx vlády x. 467/2009 Xx., xxxxxx xx xxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxx, xx xx považuje xx xxxx a xxxx je xxxxxxxx xxxxx xxx xxxx x omamných xxxxx, xxxxxxxxxxxxxx xxxxx, přípravků xx xxxxxxxxxxxx x xxxx
s xxxxxxxxx xx 5.1.2012
259/2013 Xx., nález XX xx xxx 23.7.2013 xx. xx. Xx. XX 13/12 xx xxxx návrhu xx zrušení §289 xxxx. 2 xxxxxx x. 40/2009 Xx., xxxxxxx zákoník
x xxxxxxxxx od 23.8.2013
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx v xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx jich xxxxxx derogační změna xxxxx uvedeného xxxxxxxx xxxxxxxx.